کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2847167 | 1167337 | 2013 | 7 صفحه PDF | دانلود رایگان |
Phosphodiesterases (PDEs) are known as a super-family of 11 isoenzymes, which can exert various functions based on their organ distribution. Aside from non-selective PDE inhibitors (methylxanthines, e.g. theophylline) used many years in clinical settings, increasing attention is focused on the involvement of selective PDE inhibitors in therapy of obstructive airway diseases associated with chronic inflammation. There are mostly PDE3, PDE4, and PDE7 isoforms present in the respiratory system. This paper describes the mechanisms of action, adverse effects, and potential clinical use of both non-selective and selective PDE inhibitors. The focus of the review is on the influence of PDE inhibitors on the immune system.
► Phosphodiesterases (PDEs) are involved in inflammatory changes.
► Selective and non-selective PDE inhibitors are available.
► Despite many benefits, adverse effects of PDE inhibitors should be considered.
Journal: Respiratory Physiology & Neurobiology - Volume 187, Issue 1, 1 June 2013, Pages 11–17